Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 147

1.

Patient-reported outcome measures in urology.

Narang GL, Pannell SC, Laviana AA, Huen KHY, Izard J, Smith AB, Bergman J.

Curr Opin Urol. 2017 Jul;27(4):366-374. doi: 10.1097/MOU.0000000000000412.

PMID:
28505039
2.

Long-term use of antibiotics and risk of colorectal adenoma.

Cao Y, Wu K, Mehta R, Drew DA, Song M, Lochhead P, Nguyen LH, Izard J, Fuchs CS, Garrett WS, Huttenhower C, Ogino S, Giovannucci EL, Chan AT.

Gut. 2017 Apr 4. pii: gutjnl-2016-313413. doi: 10.1136/gutjnl-2016-313413. [Epub ahead of print]

PMID:
28377387
3.

The Host Microbiome Regulates and Maintains Human Health: A Primer and Perspective for Non-Microbiologists.

Thomas S, Izard J, Walsh E, Batich K, Chongsathidkiet P, Clarke G, Sela DA, Muller AJ, Mullin JM, Albert K, Gilligan JP, DiGuilio K, Dilbarova R, Alexander W, Prendergast GC.

Cancer Res. 2017 Apr 15;77(8):1783-1812. doi: 10.1158/0008-5472.CAN-16-2929. Epub 2017 Mar 14. Review.

PMID:
28292977
4.

An analysis of the readability of patient information materials for common urological conditions.

Dalziel K, Leveridge MJ, Steele SS, Izard JP.

Can Urol Assoc J. 2016 May-Jun;10(5-6):167-170.

5.

Fecal Microbiome in Epidemiologic Studies-Letter.

Drew DA, Lochhead P, Abu-Ali G, Chan AT, Huttenhower C, Izard J.

Cancer Epidemiol Biomarkers Prev. 2016 May;25(5):869. doi: 10.1158/1055-9965.EPI-16-0063. Epub 2016 Mar 9. No abstract available.

6.

A synthetic growth switch based on controlled expression of RNA polymerase.

Izard J, Gomez Balderas CD, Ropers D, Lacour S, Song X, Yang Y, Lindner AB, Geiselmann J, de Jong H.

Mol Syst Biol. 2015 Nov 23;11(11):840. doi: 10.15252/msb.20156382.

7.

Root Causes and Modifiability of 30-Day Hospital Readmissions after Radical Cystectomy for Bladder Cancer.

James AC, Izard JP, Holt SK, Calvert JK, Wright JL, Porter MP, Gore JL.

J Urol. 2016 Apr;195(4 Pt 1):894-9. doi: 10.1016/j.juro.2015.10.175. Epub 2015 Nov 7.

PMID:
26555956
8.

Relevance of graph literacy in the development of patient-centered communication tools.

Nayak JG, Hartzler AL, Macleod LC, Izard JP, Dalkin BM, Gore JL.

Patient Educ Couns. 2016 Mar;99(3):448-454. doi: 10.1016/j.pec.2015.09.009. Epub 2015 Oct 9.

PMID:
26481910
9.

Design and feasibility of integrating personalized PRO dashboards into prostate cancer care.

Hartzler AL, Izard JP, Dalkin BL, Mikles SP, Gore JL.

J Am Med Inform Assoc. 2016 Jan;23(1):38-47. doi: 10.1093/jamia/ocv101. Epub 2015 Aug 9.

10.

Outcomes of squamous histology in bladder cancer: a population-based study.

Izard JP, Siemens DR, Mackillop WJ, Wei X, Leveridge MJ, Berman DM, Peng Y, Booth CM.

Urol Oncol. 2015 Oct;33(10):425.e7-13. doi: 10.1016/j.urolonc.2015.06.011. Epub 2015 Jul 18.

PMID:
26199176
11.

The dynamic nature and territory of transcriptional machinery in the bacterial chromosome.

Jin DJ, Cagliero C, Martin CM, Izard J, Zhou YN.

Front Microbiol. 2015 May 21;6:497. doi: 10.3389/fmicb.2015.00497. eCollection 2015. Review.

12.

Persistent, Unexplained Leukocytosis Is a Paraneoplastic Syndrome Associated With a Poor Prognosis in Patients With Urothelial Carcinoma.

Izard JP, Gore JL, Mostaghel EA, Wright JL, Yu EY.

Clin Genitourin Cancer. 2015 Aug;13(4):e253-8. doi: 10.1016/j.clgc.2015.02.008. Epub 2015 Mar 5.

PMID:
25882979
13.

The Role of Population-Based Observational Research in Bladder Cancer.

Robinson AG, Izard JP, Booth CM.

Bladder Cancer. 2015 Oct 26;1(2):123-131. Review.

14.

Microbiota, oral microbiome, and pancreatic cancer.

Michaud DS, Izard J.

Cancer J. 2014 May-Jun;20(3):203-6. doi: 10.1097/PPO.0000000000000046. Review.

15.

Relating the metatranscriptome and metagenome of the human gut.

Franzosa EA, Morgan XC, Segata N, Waldron L, Reyes J, Earl AM, Giannoukos G, Boylan MR, Ciulla D, Gevers D, Izard J, Garrett WS, Chan AT, Huttenhower C.

Proc Natl Acad Sci U S A. 2014 Jun 3;111(22):E2329-38. doi: 10.1073/pnas.1319284111. Epub 2014 May 19.

16.

User-centered design of quality of life reports for clinical care of patients with prostate cancer.

Izard J, Hartzler A, Avery DI, Shih C, Dalkin BL, Gore JL.

Surgery. 2014 May;155(5):789-96. doi: 10.1016/j.surg.2013.12.007. Epub 2013 Dec 14.

17.

Role of maximal endoscopic resection before cystectomy for invasive urothelial bladder cancer.

James AC, Lee FC, Izard JP, Harris WP, Cheng HH, Zhao S, Gore JL, Lin DW, Porter MP, Yu EY, Wright JL.

Clin Genitourin Cancer. 2014 Aug;12(4):287-91. doi: 10.1016/j.clgc.2014.01.005. Epub 2014 Jan 23.

PMID:
24560087
18.

Prostate cancer that is within 0.1 mm of the surgical margin of a radical prostatectomy predicts greater likelihood of recurrence.

Izard JP, True LD, May P, Ellis WJ, Lange PH, Dalkin B, Lin DW, Schmidt RA, Wright JL.

Am J Surg Pathol. 2014 Mar;38(3):333-8. doi: 10.1097/PAS.0000000000000162.

19.

Identification of underserved areas for urologic cancer care.

Mossanen M, Izard J, Wright JL, Harper JD, Porter MP, Daratha KB, Holt SK, Gore JL.

Cancer. 2014 May 15;120(10):1565-71. doi: 10.1002/cncr.28616. Epub 2014 Feb 12.

20.

A prospective study of periodontal disease and risk of gastric and duodenal ulcer in male health professionals.

Boylan MR, Khalili H, Huang ES, Michaud DS, Izard J, Joshipura KJ, Chan AT.

Clin Transl Gastroenterol. 2014 Feb 13;5:e49. doi: 10.1038/ctg.2013.14.

Supplemental Content

Support Center